[Clinical observation on treatment of 38 cases of postoperational large intestinal cancer by fuzheng yiai decoction combined with chemotherapy].
OBJECTIVE
To investigate the clinical value of Fuzheng Yiai Decoction (FZYAD) in postoperational large intestinal Cancer after treatment.


METHODS
Thirty-eight cases treated by FZYAD combined with chemotherapy in the treated group were observed and compared with 30 patients in the control group treated with chemotherapy alone.


RESULTS
After treatment, patients' physical strength of the treated group was better than that of the control group (P < 0.01), meanwhile, the median survival time was longer (31.4 months vs 18 months, P < 0.01), the survival rate higher (P < 0.05), and the recurrence rate lower (21.05% vs 48.34%, P < 0.05) in comparison of the treated group and the control group. Moreover, the cellular immune function of the treated group was improved after treatment.


CONCLUSIONS
In treatment of postoperational large intestinal cancer, the effect of FZYAD combined chemotherapy is better than that of chemotherapy alone in immune function regulation, cancer inhibition, relapse prevention and survival time prolongation.
Guo
Z
Z
Affiliated Hospital, Sichuan Academy of Traditional Chinese Medicine and Pharmacology, Chengdu (610041).
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000601:surgery
D004365:Drugs, Chinese Herbal